Intent To Grant an Exclusive License for U.S. Government-Owned Invention, 49074 [2018-21152]

Download as PDF amozie on DSK3GDR082PROD with NOTICES1 49074 Federal Register / Vol. 83, No. 189 / Friday, September 28, 2018 / Notices c. Whether Data Collection requests are aligned with how institutions maintain information or utilize current technologies; d. Whether Data Collections have provided helpful insight into particular markets, and whether there are other collections that would prove more insightful; and e. Ways the Bureau may interact with industry or consumer groups to gather suggestions on how to reduce reporting burden and increase the effectiveness of its Data Collections. 6. Changes the Bureau could make to existing Data Collections, or potential new Data Collections the Bureau could collect, consistent with its statutory authority, to more effectively meet the statutory purposes and objectives as set forth in section 1021 of the Dodd-Frank Act: a. The statutory purposes set forth in section 1021(a) are: i. All consumers have access to markets for consumer financial products and services; and ii. Markets for consumer financial products and services are fair, transparent, and competitive. b. The statutory objectives set forth in section 1021(b) are: i. Consumers are provided with timely and understandable information to make responsible decisions about financial transactions; ii. Consumers are protected from unfair, deceptive, or abusive acts and practices and from discrimination; iii. Outdated, unnecessary, or unduly burdensome regulations are regularly identified and addressed in order to reduce unwarranted regulatory burdens; iv. Federal consumer financial law is enforced consistently, without regard to the status of a person as a depository institution, in order to promote fair competition; and v. Markets for consumer financial products and services operate transparently and efficiently to facilitate access and innovation. 7. Other activities that the Bureau could engage in to make the Data Collection requests from financial institutions more effective and efficient. 8. Areas where the Bureau has not exercised the full extent of its Data Collection authority; where Data Collections would be beneficial and align with the purposes and objectives of the applicable Federal consumer financial laws; and/or where the Bureau can better leverage data as a strategic asset to increase effectiveness. Authority: 12 U.S.C. 5511(c); 12 U.S.C. 5492(a). VerDate Sep<11>2014 19:22 Sep 27, 2018 Jkt 244001 Dated: September 24, 2018. Mick Mulvaney, Acting Director, Bureau of Consumer Financial Protection. [FR Doc. 2018–21162 Filed 9–27–18; 8:45 am] BILLING CODE 4810–AM–P DEPARTMENT OF DEFENSE Department of the Army Intent To Grant an Exclusive License for U.S. Government-Owned Invention Department of the Army, DoD. Notice. AGENCY: ACTION: In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable biological materials license. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: Mr. Barry Datlof, Office of Research & Technology Applications, (301) 619– 0033, telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable biological materials license to 45AZ Dengue-1 strain to PrimeVax Immuno-Oncology, Inc., having its principal place of business at 2229 W Mills Drive, Orange, California 92868. Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). SUMMARY: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2018–21152 Filed 9–27–18; 8:45 am] BILLING CODE 5001–03–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DOD–2018–HA–0045] Submission for OMB Review; Comment Request Office of the Assistant Secretary of Defense for Health Affairs, DoD. ACTION: 30-Day information collection notice. AGENCY: PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 The Department of Defense has submitted to OMB for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act. DATES: Consideration will be given to all comments received by October 29, 2018. ADDRESSES: Comments and recommendations on the proposed information collection should be emailed to Ms. Cortney Higgins, DoD Desk Officer, at oira_submission@ omb.eop.gov. Please identify the proposed information collection by DoD Desk Officer, Docket ID number, and title of the information collection. FOR FURTHER INFORMATION CONTACT: Fred Licari, 571–372–0493, or whs.mcalex.esd.mbx.dd-dod-informationcollections@mail.mil. SUPPLEMENTARY INFORMATION: Title; Associated Form; and OMB Number: Department of Defense Patient Safety Culture Survey; OMB Control Number 0720–0034. Type of Request: Revision. Number of Respondents: 9,200. Responses per Respondent: 1. Annual Responses: 9,200. Average Burden per Response: 10 minutes. Annual Burden Hours: 1,533. Needs and Uses: The 2001 National Defense Authorization Act contains specific sections addressing patient safety in military and veterans’ health care systems. This legislation states that the Secretary of Defense shall establish a patient care error reporting and management system to study occurrences of errors in patient care and that one purpose of the system should be to ‘‘identify systemic factors that are associated with such occurrences’’ and ‘‘to provide for action to be taken to correct the identified systemic factors’’ (Sec. 754, items b2 and b3). In addition, the legislation states that the Secretary shall ‘‘continue research and development investments to improve communication, coordination, and team work in the provision of health care’’. (Sec. 754, item d4). In its ongoing response to this legislation and in support of its mission to ‘‘promote a culture of safety to eliminate preventable patient harm by engaging, educating and equipping patient-care teams to institutionalize evidence-based safe practices,’’ the DoD Patient Safety Program plans to field the Department of Defense Patient Safety Culture Survey. The Culture Survey is based on the Department of Health and Human Services’ Agency for Healthcare Research and Quality’s validated survey instrument. The survey obtains MHS staff opinions on patient safety issues SUMMARY: E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 83, Number 189 (Friday, September 28, 2018)]
[Notices]
[Page 49074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21152]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License for U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with applicable laws and regulations, 
announcement is made of the intent to grant an exclusive within a field 
of use, royalty-bearing, revocable biological materials license.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT:  Mr. Barry Datlof, Office of Research 
& Technology Applications, (301) 619-0033, telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7(a)(1)(i), announcement is made of the intent to grant an 
exclusive within a field of use, royalty-bearing, revocable biological 
materials license to 45AZ Dengue-1 strain to PrimeVax Immuno-Oncology, 
Inc., having its principal place of business at 2229 W Mills Drive, 
Orange, California 92868.
    Anyone wishing to object to grant of this license can file written 
objections along with supporting evidence, if any, within 15 days from 
the date of this publication. Written objections are to be filed with 
the Command Judge Advocate (see ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2018-21152 Filed 9-27-18; 8:45 am]
 BILLING CODE 5001-03-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.